14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:XLRN
Delisted

Acceleron Pharma Inc. Stock Price (Quote)

NASDAQ Stock Exchange
Open Broker Account
$178.75
+0 (+0%)
At Close: May 27, 2022
Forecast Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $178.75 $178.75 Friday, 27th May 2022 XLRN stock ended at $178.75. During the day the stock fluctuated 0% from a day low at $178.75 to a day high of $178.75.
90 days $178.75 $178.75
52 weeks $113.49 $189.99

Historical Acceleron Pharma Inc. prices

Date Open High Low Close Volume
Feb 09, 2022 $178.75 $178.75 $178.75 $178.75 0
Feb 08, 2022 $178.75 $178.75 $178.75 $178.75 0
Feb 07, 2022 $178.75 $178.75 $178.75 $178.75 0
Feb 04, 2022 $178.75 $178.75 $178.75 $178.75 0
Feb 03, 2022 $178.75 $178.75 $178.75 $178.75 0
Feb 02, 2022 $178.75 $178.75 $178.75 $178.75 0
Feb 01, 2022 $178.75 $178.75 $178.75 $178.75 0
Jan 31, 2022 $178.75 $178.75 $178.75 $178.75 0
Jan 28, 2022 $178.75 $178.75 $178.75 $178.75 0
Jan 27, 2022 $178.75 $178.75 $178.75 $178.75 0
Jan 26, 2022 $178.75 $178.75 $178.75 $178.75 0
Jan 25, 2022 $178.75 $178.75 $178.75 $178.75 0
Jan 24, 2022 $178.75 $178.75 $178.75 $178.75 0
Jan 21, 2022 $178.75 $178.75 $178.75 $178.75 0
Jan 20, 2022 $178.75 $178.75 $178.75 $178.75 0
Jan 19, 2022 $178.75 $178.75 $178.75 $178.75 0
Jan 18, 2022 $178.75 $178.75 $178.75 $178.75 0
Jan 14, 2022 $178.75 $178.75 $178.75 $178.75 0
Jan 13, 2022 $178.75 $178.75 $178.75 $178.75 0
Jan 12, 2022 $178.75 $178.75 $178.75 $178.75 0
Jan 11, 2022 $178.75 $178.75 $178.75 $178.75 0
Jan 10, 2022 $178.75 $178.75 $178.75 $178.75 0
Jan 07, 2022 $178.75 $178.75 $178.75 $178.75 0
Jan 06, 2022 $178.75 $178.75 $178.75 $178.75 0
Jan 05, 2022 $178.75 $178.75 $178.75 $178.75 0
Click to get the best stock tips daily for free!

About Acceleron Pharma Inc.

Acceleron Pharma. Acceleron Pharma Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of protein therapeutics for cancer and rare diseases. It is developing sotatercept to treat patients with chronic kidney disease, including mineral-bone disorder, vascular calcification, and anemia; and luspatercept to treat anemia and associated complications in patients with myelodysplastic syndromes and beta-thalassem... XLRN Profile

Golden Star

Ticker Date Change Price
MLI Apr 19 11.73% $52.28
LPLA Apr 19 1.08% $262.59
DOOR Apr 18 0.274% $131.39
LNG Apr 17 1.63% $156.81
FCN Apr 16 3.70% $207.62
ELV Apr 16 6.45% $506.97
AKR Apr 05 5.14% $16.53
ITCI Apr 05 5.39% $68.44
SARK Mar 28 14.47% $26.88
ARCC Mar 25 2.53% $20.12
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT